William H. Rastetter - Jun 9, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 04:43 PM
Previous filing
May 20, 2022
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Award $0 +8.65K +322.64% $0.00 11.3K Jun 9, 2022 Direct F1
holding FATE Common Stock 147K Jun 9, 2022 By The Rastetter Family Trust, dated 09/02/10 F2
holding FATE Common Stock 459K Jun 9, 2022 By The Investment 2002 Trust, dated 11/11/02 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Award $0 +11.9K $0.00 11.9K Jun 9, 2022 Common Stock 11.9K $23.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.
F2 These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.
F3 These shares are owned of record by The Investment Trust, dated November 11, 2002, for which William H. Rastetter is the sole trustee and owner.
F4 The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.